Bendahhou S. Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes.
2008.-Andersen's syndrome is a rare disorder that has been defined with a triad: periodic paralysis, cardiac arrhythmia, and development anomalies. Muscle weakness has been reported in two-thirds of the patients. KCNJ2 remains the only gene linked to Andersen's syndrome; this gene encodes for the ␣-subunit of the strong inward-rectifier K ϩ channel Kir2.1. Several studies have shown that Andersen's syndrome mutations lead to a loss of function of the K ϩ channel activity in vitro. However, ex vivo studies on isolated patient muscle tissue have not been reported. We have performed muscle biopsies of controls and patients presenting with clinically and genetically defined Andersen's syndrome disorder. Myoblasts were cultured and characterized morphologically and functionally using the whole cell patch-clamp technique. No morphological difference was observed between Andersen's syndrome and control myoblasts at each passage of the cell culture. Cellular proliferation and viability were quantified in parallel with direct cell counts and showed no difference between control and Andersen's syndrome patients. Moreover, our data show no significant difference in myoblast fusion index among Andersen's syndrome and control patients. Current recordings carried out on myotubes revealed the absence of an inwardly rectifying Ba 2ϩ -sensitive current in affected patient cells. One consequence of the Ik1 current loss in Andersen's syndrome myotubes is a shift of the resting membrane potential toward depolarizing potentials. Our data describe for the first time the functional consequences of Andersen's syndrome mutations ex vivo and provide clues to the K ϩ channel pathophysiology in skeletal muscle.
skeletal muscle; Andersen's syndrome; potassium ion channels SKELETAL MUSCLE EXCITABILITY relies not only on an integrated tissue structure but also on many functional proteins such as ion channels. This has been well exemplified through ion channel-associated disorders. In the late 1960s, it was established that muscle fibers from myotonic goats had an abnormally low Cl Ϫ conductance (8) . The first genetic link between ion channels and skeletal muscle disorders came up in the early 1990s, through the identification of the first human Na ϩ channel mutation associated with periodic paralysis (13, 22) . Since then, many mutations have been identified on Ca 2ϩ , Cl Ϫ , and K ϩ channels and were associated with disorders of the skeletal muscle (1, 16, 17, (21) (22) (23) (24) . Nondystrophic disorders of the skeletal muscle include mainly three different forms of periodic paralysis (hyper-, hypo-, and normokalemic), paramyotonia congenita, myotonia, and Andersen's syndrome (AS). Although periodic paralysis, myotonia, and paramyotonia congenita patients present only with skeletal muscle dysfunctions related to cell excitability, AS patients have a more complex phenotype. In addition to periodic paralysis and cardiac arrhythmia, they exhibit bone malformations (3). Periodic paralyses have been described in two-third of AS patients, with a higher incidence of the hypokalemic form compared with the hyper-or normokalemic forms. AS has been linked to the KCNJ2 gene that encodes for the inward-rectifying Kir2.1 K ϩ channel (21) . This class of K ϩ channels has two membrane spanning segments, a pore region and two intracellular segments. The crystal structure has been resolved for the bacterial form KirBac1.1 (18) , confirming the overall topology and the tetrameric arrangement of the channel. Over 30 mutations have been identified on the KCNJ2 gene, and their in vitro expression leads to a loss of channel function (2, 4 -7, 9 -11, 21, 26 ). The Kir2.1 channel can form a heterotetramer, where a mutated subunit may poison the whole protein and produce a silent channel. In addition to channel-gating defects at the cell membrane, channel trafficking has also been reported as a mechanism in AS mutants (5) .
AS patients present with cardiac arrhythmias that include frequent ventricular ectopy, polymorphic ventricular tachycardia, bidirectional ventricular tachycardia, and torsades de pointes. A hallmark of AS individuals is the presence of prominent U waves on electrocardiograms. In the heart, Kir2.1 channels produce what is known as the Ik1 current that mainly acts in the late repolarizing phase of the cardiac action potential and also in setting the cardiac myocyte resting membrane potential (RMP; see Ref. 20) . This situation is less clear in the skeletal muscle tissue because of the prominent Cl Ϫ conductance at rest and the structural complexity of this tissue. To date, all available data on the functional consequences of AS mutations come from in vitro expression of these channels either in Xenopus oocytes or from mammalian expression studies. In the present study, we monitor the behavior of the Ik1 current in human myoblasts from control individuals and from AS patients.
Kir2.1 channels have been shown to underlay myotube hyperpolarization, a prerequisite for myoblast fusion and differentiation (12, 19) . Using a Kir2.1 anti-sense RNA strategy in clonal human skeletal muscle cultures, Fischer-Lougheed and colleagues (12) showed that silencing Kir2.1 function leads to defective myoblast fusion and inhibits myotube formation. These observations are interesting and may contribute to explaining the developmental anomalies in AS patients. In the present study, we address this issue using AS myoblasts with naturally occurring mutations in their native environment.
MATERIALS AND METHODS

Patients
Patient A1. A 31-yr-old man, presented, since the second decade of life, with episodes of painful cramps and contractures after intense exercise followed by 24 -48 h of extreme fatigue. Other trigger factors described were stress and infections. During these episodes, creatine kinase values were two-to threefold of normal values, but no myoglobinuria was noted. The frequency of these episodes increased with age from 1/mo to 1-2/wk. There was no history of tobacco, alcohol, or drug abuse; he left school at the age of 16 due to learning difficulties and is now unemployed.
His past medical history included delayed dentition and surgical intervention for cleft palate repair. His father (patient A2) experienced the same symptoms from the age of 15 until the age of 50. The paternal grandfather died suddenly at the age of 45 with no apparent risk factors for coronary heart disease.
Patient A1 had short stature (156 cm), a distinctive craniofacial dysmorphism that included broad forehead, mild facial asymmetry, downslanting palpebral fissures, thin upper lip, long nose, dental anomalies (crowing of teeth and enamel abnormalities), and high arched palate. Neurological exam was remarkable for proximal symmetric weakness of lower limbs. The diagnosis was established because he presented an episode of hypokalemic generalized paralysis after corticosteroid therapy for pharyngolaryngitis. Electrocardiogram revealed the presence of a prominent U wave with a normal QTc interval.
Patient A2. Patient A2 is the father of patient A1. He is a 68-yr-old man who has experienced from the age of 15 painful cramps and contractures after sustained exercise followed by 24 -48 h fatigue that made him unable to walk. No myoglobinuria was ever referred. The frequency of these episodes was one to two times a week when he was 25 and 35 and then decreased until disappearing at the age of 50. The trigger factors he described were exercise, immobility, stress, infections, and cold. He apparently never experienced hypokalemic periodic paralysis. He left school at the age of 13 and worked in a factory, but is now retired. He was diagnosed with type II diabetes and arterial hypertension at the age of 45. Physical examination showed short stature (150 cm), mild facial asymmetry, downslanting palpebral fissures, dental anomalies (crowing of teeth and enamel abnormalities), and scoliosis. The neurological examination and cardiac investigations were unremarkable.
Analysis of the KCNJ2 gene revealed a missense mutation G689A corresponding to the amino acid substitution C154Y on the Kir2.1 protein, in both patients A1 and A2.
Patient A3. A 37-yr-old Caucasian man with a positive family history (mother and younger brother affected) presented, since the age of 29, episodes of hypokalemic periodic paralysis, with a frequency of two to three episodes per year. Major triggers were exercise, rest postexercise, and stress. Apart from these episodes, he experienced episodic pain associated with sustained cramps in the lower legs, mostly in the calves, and in his hands. At the examination, he presented slight dysmorphisms that include short palpebral fissures, thin upper lips, high arched palate, mild facial asymmetry, and long nose. Electrocardiogram analysis revealed the presence of U waves. Muscle biopsy was performed on vastus lateralis muscle, but histological and immunohistochemical examinations were normal.
The patient harbored a G1163A mutation on the KCNJ2 gene leading to the R312H amino acid substitution on the Kir2.1 protein.
Myotonia patient. The next patient was a 63-yr-old man who had been experiencing myotonia since childhood. The myotonia was increased by cold, hunger, fatigue, and emotional upset and associated with myalgia. He also complained since the age of 45 of difficulty in climbing stairs. At the clinical and neurological examination, he displayed generalized muscle hypertrophy without any muscle weakness at rest. The creatine kinase values were normal. The electromyographic evaluation showed myotonia that was most evident in distal territories and was worsened by cold.
The disease is present in the family as an autosomal dominant trait. A mutation that corresponds to G230E amino acid substitution of the muscular Cl Ϫ channel (ClC-1) that has already been described as pathogenic (14) was found in all affected members.
Cell Culture Set Up and Expansion
Myoblasts were obtained from vastus lateralis muscle biopsies (dry wt ϳ200 g) from three AS patients during the diagnostic process and as res nullus after orthopedic surgery from two matched controls. The cells were seeded as described earlier (27) . The proliferation medium contained 80% Ham's F-10 (Invitrogen), 20% defined FBS (Hyclone), antibiotics, 10 ng/ml human recombinant basic fibroblast growth factor (bFGF; R&D Systems), and 10 Ϫ6 M dexamethasone (Merck). The cultures were harvested by trypsinization and expanded until they reached 80% confluence. Cell morphology was observed at each passage by inverted phase-contrast microscopy. In parallel, a phenotypic characterization was performed.
Phenotypic Characterization
Myogenic cells were characterized by the presence of the surface CD56 antigen. At each passage, direct labeling was performed using the phycoerythrin-coupled anti-CD56 antibody (Becton-Dickinson). Nonspecific labeling was evaluated using the control isotype (IgG 2b; Pharmingen). Following centrifugation, the pellet was rinsed with PBS, and the cells were suspended under 200 l and, then analyzed by fluorescence-activated cell sorter (FACS) analysis (Facscalibur; BectonDickinson) using the Cell Quest software. At least 10 4 events were analyzed. The whole cell population was visualized using a dot-plot representation [forward scatter (FSC) vs. side scatter], and the cell labeling was quantified using the density plot representation (FSC vs. red fluorescence).
Myoblasts Proliferation Studies
Populations of myoblasts at passage 5 of culture, containing Ͼ95% CD56 positive cells, were used (see above). Cells (10 4 ) were seeded in 12-well dishes in 1-ml proliferation medium. Each point was evaluated in triplicate. Each consecutive day, three wells were ran-domly selected for harvesting and counting of the cells. The medium was removed using a tip, the cell layer was washed one time with prewarmed Ca 2ϩ /Mg 2ϩ -free PBS, and 500 l of prewarmed trypsin-EDTA (0.25%; GIBCO) were added. Cells were incubated for 5 min and suspended by several cycles of aspirations and flow reversal using a 2-ml pipette. Their detachment and the homogeneity of the suspension were controlled by a microscope inspection; 20 l were used for cell count using a Malassez glass cytometer (all lines counted). The calculation formula was as follows:
where T is the total number of cells per milliliter of initial suspension, n is the number of cells in the counting area of the slide, and dilution is 0.5 in the present study.
The mean of the three wells was calculated. The proliferation study generally extended over 5-6 days. By that time, confluence was reached and formation of myotubes was observed. Doubling times were calculated as previously described (27) . At the beginning and at the end of the study, CD56 phenotyping was performed by FACS to check if the CD56 percentage remained stable during the proliferation test.
Viability Assessment
Following trypsinization and a wash with PBS, 140 l of cell suspension were mixed with 50 l of 0.3 mg/ml 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT; Roche) for 4 h at 37°C. Absorbance was measured spectrophotometrically at 490 nm using an ELISA plate reader. An increase of the number of living cells results in an increase in the overall activity of mitochondrial dehydrogenases in the sample. This increase is directly correlated to the amount of orange formazan formed, as monitored by the absorbance.
Differentiation Studies
Twenty thousand cells (CD56 purity Ͼ95%) were seeded in 12-well plate chamber slides and allowed to proliferate for 72 h. Differentiation was induced by replacement of the proliferation medium to the differentiation medium containing Ham's F-10 (98%; Invitrogen%), 2% FBS, and antibiotics. At different time points corresponding respectively to the cell cycle withdrawal (D0), 24 hours (D1), 72 hours (D3) and 144 hours (D6) after inducing differentiation, cells were permeabilized and fixed by cold methanol (Ϫ20°C, 5 min). The cells were stained for isoforms of myosin heavy chain (MyHC): anti-fast MyHC (Sigma) and anti-slow MyHC (Sigma). Following incubation with goat anti-mouse (Ig Alexa Fluor 568), the cells were mounted under cover slips using the Vectashield Plus DAPI solution (Vector). Negative controls were obtained by substitution of the primary antibody with nonimmune serum. The cells were visualized using an inverted microscope equipped with fluorescence (Olympus Optical). Pictures were acquired using a Photometric digital camera. The number of nuclei stained with DAPI, in mononuclear cells and in multinuclear structures (myotubes from controls and AS), were determined at D3 and D6 after inducing differentiation (at least 500 myotubes were considered in 5-10 randomly selected fields). The fusion index was calculated using the formula: FI ϭ ͓͑no. of nuclei within myotube structures͒/ ͑total no. of nuclei in the field͒ ϫ 100͔.
Cell Culture and Electrophysiology
Human myoblasts cultured and characterized as described above were maintained at 37°C in a humidified 5% CO 2 atmosphere in the following culture medium: 80% Ham's F-10, 20% calf serum, 10 ng/ml bFGF, 1 M dexamethasone, 2 mM glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin.
Cells were differentiated using the following medium: DMEM, 10 g/ml human insulin, 100 g/ml sodium pyruvate, 5 g bovine transferrin, 100 U/ml penicillin, and 100 U/ml streptomycin. A2, and A3) , at D0 and at D6 of differentiation. Recordings were conducted in the whole cell configuration (15) at room temperature (ϳ24°C), using an EPC 10 amplifier (HEKA Electronic). The pipette solution contained (in mM): 110 KCl, 5 mM NaCl, 2 MgCl 2, 10 EGTA, and 5 mM HEPES, pH 7.3. The bathing media was (in mM): 100 N-methyl-D-glucamine chloride, 5 KCl, 2 MgCl2, 50 NaOH, 50 acetic acid, and 5 HEPES, pH 7.3. Pipette resistance was 1.5-4 M⍀. Membrane currents were elicited by depolarizations ranging from Ϫ120 to ϩ40 mV, from a holding potential of Ϫ80 mV. Only cells with series resistance Ͻ5 M⍀ were used for analysis. Data acquisition and analysis were performed using Patchmaster and Fitmaster (HEKA Electronic) and IgorPro (WaveMetrics) software.
RMP was monitored using patch and sharp electrodes. Measurement of RMP with patch electrodes was achieved by switching the amplifier from whole cell mode to current clamp mode and by applying zero current value. RMP was also monitored with intracellular sharp electrodes filled with 3 M KCl. Borosilicate glass capillaries (GC 150 F; Clark Electromedical Instruments) were pulled with a Brown-Flamming puller (P97; Sutter Instruments) and had resistances of 150 -200 M⍀.
RESULTS
Cell Culture, Morphology, Phenotypic Characterization
We have identified three AS patients and two novel mutations, C154Y and R312H, in the Kir2.1 protein. The two amino acid substitutions occur at two known sites associated with AS (7, 10) and produce a loss of function when studied in vitro. Biopsies from vastus lateralis muscle were performed on each patient as well as on matched controls. No morphological difference was observed between AS and control myoblasts at each passage of the cell culture. The percentage of CD56-positive cells reached a plateau (Ͼ90%) within two passages and remained elevated throughout the culture in both control and AS cell cultures.
Myoblast Proliferation and Viability Study
Cell viability was evaluated by a colorimetric assay at each step of the cultures. The assay was based on the cleavage of the yellow tetrazolium salt XTT in an orange formazan dye by metabolically active cells. This conversion occurs only in living cells and is catalyzed by mitochondrial dehydrogenases (25) . Cellular proliferation and viability were quantified through the XTT assays in parallel with the direct cell counts (data not shown). Proliferation curves reached maximal growth rates between D3 and D4, then doubling times remained stable until D5 (Fig. 1) . Between D4 and D5, control cells reached a doubling time of ϳ24 h (i.e., 23.97 Ϯ 0.75 h). At the same time, cells from the three AS patients showed similar doubling times (23.50, 24.67, and 22.17 h). The mean doubling time of AS cells was similar to controls (23.44 Ϯ 1.25 h). Linear correlation between XTT absorbance and cell counts was confirmed, showing viability rates at D4 and D5 between 80 and 95%.
Differentiation Studies
It has been previously suggested that the Kir2.1 channel is involved in cell membrane hyperpolarization, which is required for myoblast fusion and differentiation. Therefore, the alteration in Kir2.1 function may result in impaired myoblast fusion and inhibition of myotube formation (12) . These results prompted us to study the in vitro myogenic differentiation of AS myoblasts by three different approaches. The myoblast fusion index was calculated at four different time points after inducing differentiation; however, no statistically significant difference was detected between control and AS cell cultures (80, 88, and 87% for AS cells, and 83% in both controls; Table 1 ). In addition, the average number of nuclei within the AS myotubes was comparable to the controls (control, 4.1 Ϯ 3 and AS, 4.2 Ϯ 2.8 for D3; control, 12 Ϯ 1.2 and AS, 12.1 Ϯ 1 for D6). There was also no difference in myotube morphology nor in fast or slow MyHC expression immunostaining (Fig. 2) .
Ionic Currents in Control Human Muscle Cells
Human myoblasts obtained from biopsied patients undergoing orthopedic surgery were cultured in 35-mm dishes in normal culture medium. Current recordings were performed 24 h later on isolated cells to prevent cell coupling. In these conditions, only small inward and outward currents were recorded (Fig. 3A) . The outward current is likely to be carried out by Kv2.1 channels, as has already been described in H9c2 myoblasts (28) . After 10 days of differentiation (under insulin with low or no serum), the outward currents became larger, and additional currents were observed, including fast-inactivating currents, likely to represent the voltage-gated Na ϩ currents, and small sustained inwardly rectifying currents that we suspect to underlay Ik1 currents (Fig. 3, B, C, and E) . The fast-inactivating currents were indeed completely abolished after application of 500 nM tetrodotoxin (TTX) to the bathing medium without altering other ionic current activities (Fig.  3C) . When combining 500 M BaCl 2 and 500 nM TTX in the bathing medium, the inward-rectifier currents were also blocked (Fig. 3D) . Representative current-voltage relationships were drawn from the upper traces, at the end of the test pulse. The current amplitude of the curves represents the inward currents and outward currents. These data not only show an increase in the outward currents after cell differentiation but, more importantly to this study, an increase in an inwardly rectifying current (Fig. 3G) that is blocked by low Ba 2ϩ concentrations (Fig. 3H) .
Ionic Currents in AS Muscle Cells
Skeletal muscle biopsies from three AS patients were used to culture myoblasts as described above. Currents elicited by successive depolarizations of undifferentiated AS muscle cells show a pattern similar to that seen with undifferentiated cells from healthy individuals: small outward currents (Fig. 4, A and  B) . After differentiation, similarly to muscle cells from healthy individuals, the outward currents became larger, and fastinactivating and TTX-sensitive currents develop in most of the cells recorded. However, the inward-rectifying currents were missing in the vast majority of the cells monitored (Fig. 4, C  and D) .
Current Density in Human Muscle Cells
Overall, three kinds of currents were recorded in our experimental conditions after cell differentiation. Cell capacitance was monitored for each cell, and current density was calculated as the ratio of the current amplitude to the cell capacitance. For the inward-rectifying currents, the current amplitude was measured at Ϫ120 mV at the end of a 500-ms test pulse. The current densities were averaged for both normal controls as well as for AS patients. The current density (pA/pF) at Ϫ120 mV was significantly lower for AS patients than that for control individuals (P Ͻ 0.0001; Fig. 5,  A and B) . Maximum peak current was also monitored at Ϫ20 mV, and current density was calculated for each value. Our data show that AS muscle cells have significantly higher Na ϩ channel density than healthy individuals (P Ͻ 0.01; Fig. 5C ). However, current density at ϩ40 mV was only slightly but still significantly higher for AS patients than controls (P Ͻ 0.05; Fig. 5D ). 
AS Myotubes are Depolarized at Rest
After recording ionic currents in voltage-clamp mode, cells were switched to current-clamp mode, and rest membrane potential was measured from all differentiated muscle cells. Our data show that the rest membrane potential significantly shifted toward depolarizing potentials for AS patients compared with control individuals (Ϫ51.68 Ϯ 1.39 mV, n ϭ 38 for controls; Ϫ46.70 Ϯ 0.55 mV, n ϭ 154 for AS; P Ͻ 0.001) (Fig. 6A) . All rest membrane potential values monitored for controls as well as for AS were more depolarized than that of native muscle tissue; this is probably due to a combination of low K ϩ concentrations used in our intracellular medium and a heterogeneous cell population (19) . To further confirm that the AS RMP is more depolarized than in controls, an intracellular sharp electrode technique was used (Ϫ54.7 Ϯ 0.4 mV, n ϭ 121 for controls; Ϫ43.2 Ϯ 0.8 mV, n ϭ 83 for AS; P Ͻ 0.0001) (Fig. 6B) .
Ionic Currents in a Myotonia Patient
All parameters monitored in the muscle cells of control and AS patients were compared with those of the patient with myotonia congenita, with the G230E amino acid substitution on the skeletal muscle ClC-1 Cl Ϫ channel. Whole cell current recordings from muscle cells of the myotonia patient showed a pattern similar to that of healthy individuals, i.e., large Na ϩ and outward currents and the presence of an inwardly rectifying current (Fig. 7A) . Current densities at Ϫ120 mV were not significantly different between those recorded in cells obtained from the myotonia patient and those obtained from the healthy individuals (P ϭ 0.582); however, they were significantly higher than those recorded in AS myotubes (P Ͻ 0.0001; Fig.  7B ). At Ϫ20 mV, the current density in myotonia myotubes was not significantly different from that of healthy myotubes (P ϭ 0.0526), but significantly lower than that of AS myotubes (P Ͻ 0.0001) (Fig. 7C) . The current density recorded at the end of the ϩ40-mV test pulse in myotonia myotubes was not Fig. 5 . Current density in myotubes from healthy and from Andersen's syndrome patients. A: steady-state currents were monitored at the end of the 500-ms test pulse at Ϫ120 mV for 4 healthy individuals (C1, C2, C3, and C4) and for 3 Andersen's syndrome patients (A1, A1, and A3). B: current densities were determined and averaged for controls and for Andersen's syndrome patients. C: current densities were obtained from the peak current at Ϫ20 mV test pulse for the TTX-sensitive component. D: current densities are shown for the outward current component and measured at ϩ40 mV at the end of a 500-ms test pulse. Values are means Ϯ SE. The no. of cells recorded is shown above the bars. significantly different from that of healthy (P ϭ 0.231) as well as AS myotubes (P ϭ 0.355) (Fig. 7D) . Finally, the RMP was investigated and showed that myotonia and AS myotubes were similarly and significantly depolarized compared with myotubes from healthy individuals (P Ͻ 0.001) (Fig. 7E) .
DISCUSSION
After the identification of the KCNJ2 gene as the genetic entity associated with AS, functional studies have shown, in heterologous expression systems, that the disorder is associated with a loss of function of the K ϩ channel Kir2.1 protein. The skeletal muscle manifestations in AS patients were characterized by muscle weakness, leading to either one of the three forms of periodic paralyses, without myotonia. However, the hypokalemic form was the most frequently described, since it was reported in two-thirds of the AS patients.
To better understand the skeletal muscle pathophysiology, muscle biopsies were performed on two patients with the C154Y amino acid substitution and one patient carrying the R312H mutation in the Kir2.1 protein. The three patients have typical clinical manifestations reminiscent of AS: periodic paralysis, developmental anomalies, and cardiac arrhythmia. We have previously described AS mutations occurring at the same sites (C154F and R312C) (7, 10) . The mutated channels produced a loss of function when expressed in vitro. However, their behavior as well as that of all other AS mutations has not been monitored ex vivo. Using biopsied muscle from control individuals and from three AS patients, we were able to describe cell proliferation, differentiation, fusion, and expression in these myoblasts.
We first characterized phenotypically the behavior of the cultured myoblasts. We made sure that our cell population was largely made of muscle cells, using myoblast markers, and showed that the percentage of myoblasts in the culture reached at least 98%. Cell proliferation, fusion, and differentiation were monitored for both controls and AS myoblasts during six passages. By contrast to previous studies, we did not detect any difference between myoblasts from healthy individuals and those from AS patients. Indeed, it has been suggested that the Kir2.1 channel is involved in cell membrane hyperpolarization, which is required for myoblast fusion and differentiation (12) . It has also been suggested that the alteration in Kir2.1 function would result in impaired myoblast fusion and inhibition of myotube formation. These conclusions were based on antisense RNA assays for Kir2.1 in clonal cultures. Our observations are based on naturally occurring mutations in a human tissue without any modification of the cellular environment. Overexpressing antisense RNA in myoblasts may have interfered not only with Kir2.1 expression but with other cellular pathways required for proliferation and fusion. Additionally, using antisense RNA for Kir2.1 may have completely knocked out the Ik1 current, which may not be the case for a K ϩ channel with a tetrameric structure in a native tissue. In fact, in an autosomal dominant disorder, and with a mutated subunit that poisons whole channel function, there is a 1 ⁄16th chance of a combination that would result in a wild-type-like channel, A: whole cell current traces from myotonia myotubes. Currents were elicited by Ϫ120 to ϩ40 mV test pulses in 20-mV increments. Current densities were determined in myotonia myotubes, at Ϫ120 mV (B), at Ϫ20 mV (C), or at ϩ40 mV (D) and were compared with Andersen's syndrome and control cells. E: resting membrane potential (V) was monitored for myotonia myotubes as described above. Values are means Ϯ SE.
which would lead to the expression of a fraction of the Ik1 current in the myoblasts. This may be sufficient to ensure myotube formation. Alternatively, other compensatory mechanisms may have taken place in AS human myoblasts, but may have been prevented in intrusive systems such as antisense RNA. Interestingly, Kir2.1 channel knockout mice die shortly after birth because of a cleft in the secondary palate, but no muscle abnormalities have been reported (29, 30) .
Further characterization of control and AS myoblasts involves the ionic activity at the cell membrane. Both cell types express the same level of the outward current when undifferentiated. Interestingly, this current resembles the outward current that has already been described in H9c2 myoblasts, a clonal cell line derived from embryonic rat ventricle and represents an in vitro model for cardiac and skeletal muscle myocytes. Kv2.1 channels were shown to underlay this current (28) . However, the ionic current composition and magnitude were not identical after cell differentiation. Cells from healthy control individuals express a large outward current, an inward TTX-sensitive current, and an inwardly rectifying Ba 2ϩ -sensitive current. Compared with control cells, AS differentiated myoblasts express all currents except the inwardly rectifying Ba 2ϩ -sensitive current that was recorded in the control cells. We hence conclude that the inwardly rectifying Ba 2ϩ -sensitive current is the signature of Kir2.1 K ϩ channel activity in human skeletal muscle myotubes. Our data also show that this is the first evidence that AS-associated Kir2.1 mutations lead to a loss of channel function in human skeletal muscle cells. The first consequence of the absence of the Ik1 current in human myoblasts is a significant depolarization of the RMP. This depolarization is similar to that seen in myotubes from a myotonia patient with a ClCN1 mutation. However, AS patients do not exhibit myotonia, but only periodic paralysis. Even though myotonia and AS myotubes have a common functional defect, the functional consequences are opposite on the skeletal muscle pathophysiology, suggesting that the two ion channels do not play the same role in the skeletal muscle structure. Although Cl Ϫ channels have buffering properties to maintain or bring back membrane potential to its initial value, K ϩ channels tend to set the cell RMP. This is a major difference between the two classes of ion channels, but it does not explain the mechanism by which AS mutations lead to muscle paralysis. Our system relies on native human cells and clearly shows the loss of Kir2.1 function in AS myotubes; however, it does not reconstitute the complex skeletal muscle architecture that may be needed to further understand the pathogenic mechanism of AS mutations.
